2025 annual financial data
Boundless Bio, Inc. 2025 Operating margin
Boundless Bio, Inc. 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -63,552,000 USD and net income was -58,197,000 USD.
Operating cash flow was -46,661,000 USD.
Get free Boundless Bio, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -63,552,000 USD
- Net income
- -58,197,000 USD
- Operating cash flow
- -46,661,000 USD